OSL Equity Snapshot

LYTIX Weekly Equity Report

Lytix Biopharma ASA

Interactive chart JSON snapshot
Latest Close 8.90 NOK 12 Jun 2026
1W Return -10.3% latest completed week
4W Return -17.6% short-term follow-through
12W Return -17.6% quarterly tape
Trend Breadth 84.6% 44 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
Company Brief

What the company does

Lytix Biopharma ASA, a clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States. Its lead product candidate is ruxotemitide, an oncolytic molecule that is developed for intratumoral injections, which is in Phase III clinical trials, to treat melanoma, basal cell carcinoma, and advanced soft tissue sarcoma; and NeoLIPA Phase II study in combination with pembrolizumab. The company also offers LTX-401, an oncolytic molecule in preclinical phase for the treatment of deep-seated tumors, such as hepatocellular carcinoma in liver cancer and liver metastases. It has a partnership with Verrica Pharmaceuticals …

Snapshot

What the weekly tape is saying

LYTIX closed the latest completed week at 8.90 NOK. The 4-week return is -17.6% and the 12-week return is -17.6%. Trend Signal is inactive, Market Dynamics is -0.21. Setup signature: Risk-first tape with a 27/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -10.9%
Volume 1.3x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 47 Persistence of active Trend Signal over the last year and current streak.
Momentum 0 Blend of 4-week and 12-week follow-through.
Dynamics 35 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 54 Participation compared with the 13-week volume baseline.
Risk Control 25 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
9.99 NOK
Vs Trend Line
-10.9%
Fair Value
7.73 NOK
Vs Fair Value
15.2%
52W High
11.90 NOK
52W Low
6.68 NOK
Drawdown
-25.2%
Range Position
42.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -10.3%
4W -17.6%
12W -17.6%
26W -11.0%
52W -6.1%

Trend read

Active Streak
0 weeks
52W Active Weeks
44
52W Active Breadth
84.6%
Sector Scope
NO Healthcare
Sector Rank
21 of 24
Sector Percentile
13.0%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.21
4W MD Change
-144.6%
Relative Strength
-16.19
4W RS Change
-19054.5%
Expectation
Undecided
Probability
51.25%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
297.1K
13W Average
231.0K
52W Average
299.3K
Vs 13W
1.3x
Vs 52W
1.0x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.9%
52W Volatility
5.9%
Upside Weeks
24
Downside Weeks
25
Downside Breadth
48.1%
Avg Gain / Loss
4.5% / -4.2%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
OSL
Country
NO
Sector
Healthcare
Industry
Biotechnology
Currency
NOK
Market Cap
811.3M

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 8.90 NOK -10.3% 9.99 NOK 7.73 NOK -0.21 -16.19 297.1K Off
5 Jun 2026 9.92 NOK -6.0% 10.04 NOK 7.72 NOK 0.18 -7.45 292.3K On
29 May 2026 10.55 NOK -4.5% 10.03 NOK 7.71 NOK 0.47 -1.56 145.8K On
22 May 2026 11.05 NOK 2.3% 9.93 NOK 7.70 NOK 0.43 0.90 205.3K On
15 May 2026 10.80 NOK -0.5% 9.81 NOK 7.70 NOK 0.47 -0.08 134.8K On
8 May 2026 10.85 NOK 8.5% 9.69 NOK 7.69 NOK 0.48 2.99 309.3K On
1 May 2026 10.00 NOK -3.8% 9.59 NOK 7.68 NOK 0.45 -6.76 66.9K On
24 Apr 2026 10.40 NOK 0.0% 9.50 NOK 7.66 NOK 0.49 -1.31 536.5K On
17 Apr 2026 10.40 NOK -3.3% 9.38 NOK 7.64 NOK 0.30 0.54 197.3K On
10 Apr 2026 10.75 NOK 3.4% 9.28 NOK 7.62 NOK 0.30 0.77 276.4K On
3 Apr 2026 10.40 NOK 2.5% 9.19 NOK 7.60 NOK 0.26 -2.35 53.7K On
27 Mar 2026 10.15 NOK -6.0% 9.10 NOK 7.57 NOK 0.06 -0.70 239.4K On
20 Mar 2026 10.80 NOK 2.4% 9.03 NOK 7.55 NOK -0.09 7.20 247.7K On
13 Mar 2026 10.55 NOK 11.1% 8.98 NOK 7.52 NOK -0.40 6.70 508.0K On